To assess the effect of self care educational package on the prevention of radiotherapy induced adverse effects in patients with breast cancer.
Phase 2
- Registration Number
- CTRI/2023/07/055170
- Lead Sponsor
- isha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients willing to participate.
Patients with breast cancer undergoing radiotherapy.
Exclusion Criteria
Patients not willing to participate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in radiotherapy induced toxicity.Timepoint: 15 days <br/ ><br>T0 baseline assessment at the time of enrollment <br/ ><br>T1 assessment 1 week after enrollment <br/ ><br>T2 assessment 2 weeks after enrollment
- Secondary Outcome Measures
Name Time Method ATimepoint: NA